Feed Insights Top Reports Pricing

⌘K

17:20:37·1004d

SECFilingvia Quantisnow

SEC Form 10-K filed by IBEX Limited

ByQuantisnow·Wall Street's wire, on your screen.

IBEX· IBEX Limited

Technology

Plus alert sent

Quantisnow Plus members were alerted at 17:20:40 ET - 3.4s after publication.

Sign up for Plus

Free Quantisnow account

Get notified the moment IBEX files

Real-time alerts on SEC filings, FDA approvals, analyst ratings, insider trades, and press releases. Follow any ticker. No credit card.

Sign up free Log in

Original source

This insight was delivered by Quantisnow - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IBEX (IBEX Limited) and more on Quantisnow.

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Related

Director Mcginnis Patrick sold $32,641 worth of shares (1,030 units at $31.69), decreasing direct ownership by 15% to 5,833 units (SEC Form 4)
Chief Financial Officer Greenwald Taylor C was granted 3,333 shares and sold $30,867 worth of shares (964 units at $32.02), increasing direct ownership by 4% to 62,230 units (SEC Form 4) (for tax liability)
ibex to Present at the Baird 2026 Global Consumer, Technology & Services Conference
IBEX Limited filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
Chief Executive Officer Dechant Robert Thomas sold $237,897 worth of shares (7,800 units at $30.50), decreasing direct ownership by 3% to 285,606 units (SEC Form 4)

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds Follow on Google News

Top lists

Trending By market cap Active companies Insider purchases FDA approvals Short volume screener Sectors Market reports

Browse

By event category By exchange Earnings calendar Dividend tracker Insider tracker IPO calendar Compare stocks

Publish

Publish an article Amend a newsitem Pricing Guidelines Terms

Company

About Pricing Refer a trader25%Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022